Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification

Overview of attention for article published in Alzheimer's Research & Therapy, March 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog

twitter: 2 X users
patent: 1 patent

Citations

dimensions_citation: 153 Dimensions

Readers on

mendeley: 181 Mendeley

Summary News Blogs X Patents Dimensions citations

So far, Altmetric has seen 1 blog post.

Easy, Affordable Blood Testing for Alzheimer’s May Come Soon

Being Patient, 28 Jul 2020

A growing body of research supports blood testing as a means for an accurate and affordable diagnostic test for Alzheimer’s…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.